Organigram, Inc. is Atlantic Canada’s original licensed producer of medical cannabis. Since starting out in 2013, the company has won multiple awards for its cannabis products and services. But on Friday, the Supreme Court of Nova Scotia certified a 2017 class action lawsuit against Organigram. The court’s certification means the company will go to trial. In a statement, Organigram has vowed to fight back against the class action, which stems from pesticide contamination in the company’s medical cannabis products.
Medical Cannabis Producer Organigram Faces Class Action Suit over 2016-2017 Pesticide Contamination
Based in Moncton, New Brunswick, Organigram, Inc. is the region’s largest licensed medical cannabis supplier. But the well-known company stands accused of making its customers ill with pesticide-contaminated cannabis.
In late 2016 and early 2017, Organigram issued two, large-scale, voluntary recalls of medical cannabis produced between Feb. 1 and Dec. 16, 2016. Independent, third-party laboratory tests detected the banned pesticides myclobutanil and bifenazate in multiple lots. The lab tests prompted the product recalls, which in 2017 led to the class action lawsuit against Organigram.
Class-Action Lawsuit Against Organigram Claims Patients Suffered Adverse Health Effects
Speaking with the CBC, lawyer Ray Wagner said his clients are suing Organigram for compensation